{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T15:33:27Z","timestamp":1764516807896,"version":"3.46.0"},"reference-count":22,"publisher":"Practical Medicine Publishing House","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background.\u00a0Grade 3 follicular lymphoma (FL) is a heterogenetic group of tumors. The selections of patients with similar characteristics of the tumor process is important for classification 3 grade forms of FL and risk stratification, as well as for the development of new therapeutic approaches. Different morphological, immunohistochemical and cytogenetical characteristics of the tumor result in different clinical forms of the disease.\r\nAim.\u00a0To describe the clinical, morphological, immunohistochemical and cytogenetical characteristics of grade 3 FL and evaluate their prognostic value for R-CHOP-21 chemotherapy.\r\nMaterials &amp; Methods.\u00a0We performed retrospective and prospective analysis of morphological, immunohistochemical and genetical characteristics of 93 primary patients with grade 3 FL (21\u201378 years, median 53 years, women to men\u00a0\u2014 1:1.4) admitted to National Medical Hematology Research Center from years 2001 to 2016. Morphological and immunohistochemical assessment of the affected lymph nodes and bone marrow biopsy material was performed. Data obtained from the standard cytogenetic and FISH assessment were compared to identify the\u00a0BCL2\u00a0rearrangement.\r\nResults.\u00a0We proposed an algorithm for differential diagnosis of the 2 types of grade 3 FL:\u00a0de novo\u00a0FL (n\u00a0=\u00a022) and transformed FL (n\u00a0=\u00a021).\u00a0De novo\u00a0grade 3 FL had the immunophenotype of CD10\u2013 in 19 (86\u00a0%) cases, MUM1++ (monomorphically) in 19 (90\u00a0%), and BCL-2 in 5 (22\u00a0%). It was characterized by the absence of the\u00a0BCL2 rearrangement (n\u00a0=\u00a022, 100\u00a0%) and bone marrow involvement (n\u00a0=\u00a014, 67\u00a0%) and\/or bone marrow involvement (n\u00a0=\u00a07, 100\u00a0%). Third grade FL transformed from grades 1 or 2 had was CD10+ (n\u00a0=\u00a019, 90\u00a0%), MUM1+ (heterogeneously,\u00a0n\u00a0=\u00a016, 76\u00a0%) or MUM1\u2013 (n\u00a0=\u00a04, 19\u00a0%), BCL-2+ (n\u00a0=\u00a020, 95\u00a0%) and had\u00a0BCL2\u00a0rearrangement (n\u00a0=\u00a019, 90\u00a0%). Small cell bone marrow involvement was observed in 71\u00a0% of cases, whereas large cell involvement was seen predominantly in\u00a0de novo\u00a0FL (p\u00a0=\u00a00.06). The analysis showed that 5-year relapse-free survival in patients with grade 3\u00a0de novo\u00a0FL after R-CHOP-21 therapy was 87\u00a0% compared to 16\u00a0% with transformed FL (p\u00a0=\u00a00.06) for the median 41 months of follow up.\r\nConclusion.\u00a0We described the morphological, immunohistochemical and cytogenetical characteristics of grade 3\u00a0de novo\u00a0FL and grade 3 FL, transformed from grades 1 or 2. The described variants show different sensitivity to immunochemotherapy.<\/jats:p>","DOI":"10.21320\/2500-2139-2017-10-4-453-463","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T08:52:53Z","timestamp":1509094373000},"page":"453-463","source":"Crossref","is-referenced-by-count":1,"title":["The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data","\u0424\u043e\u043b\u043b\u0438\u043a\u0443\u043b\u044f\u0440\u043d\u0430\u044f \u043b\u0438\u043c\u0444\u043e\u043c\u0430 3-\u0433\u043e \u0446\u0438\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0442\u0438\u043f\u0430: de novo \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u043e\u0440\u043c\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 \u0432\u0430\u0440\u0438\u0430\u043d\u0442\u044b \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f"],"prefix":"10.21320","volume":"10","author":[{"given":"Lyubov\u2019 Vasil\u2019evna","family":"Plastinina","sequence":"first","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Kovrigina","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. N.","family":"Obukhova","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. S.","family":"Nesterova","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. U.","family":"Magomedova","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya. K.","family":"Mangasarova","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Misyurina","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. E.","family":"Babaeva","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Kulikov","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. I.","family":"Vorob\u2019ev","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kravchenko","sequence":"additional","affiliation":[{"name":"National Medical Hematology Research Center, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u041d\u041c\u0418\u0426 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2017,10,1]]},"reference":[{"key":"16068","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008265532487"},{"key":"16069","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoetic and Lymphoid Tissues, 4th edition. Lyon: IARC Press; 2008."},{"key":"16070","doi-asserted-by":"publisher","DOI":"10.21320\/2500-2139-2017-10-1-52-60"},{"key":"16071","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31826b9b57"},{"key":"16072","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.042531"},{"key":"16073","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.06.013"},{"key":"16074","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-045989"},{"key":"16075","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2011.02.002"},{"key":"16076","unstructured":"\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u043f\u043e \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0435 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044e \u043b\u0438\u043c\u0444\u043e\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0418.\u0412. \u041f\u043e\u0434\u0434\u0443\u0431\u043d\u043e\u0439, \u0412.\u0413. \u0421\u0430\u0432\u0447\u0435\u043d\u043a\u043e. \u041c., 2016.[Poddubnaya IV, Savchenko VG, eds. Russian Clinical Recommendations on Diagnosis and Treatment of Lymphoproliferative Diseases. Moscow; 2016. (In Russ)]"},{"key":"16077","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.802778"},{"key":"16078","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq574"},{"key":"16079","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08942.x"},{"key":"16080","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl039"},{"key":"16081","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw185"},{"key":"16082","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601006"},{"key":"16083","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.3990"},{"key":"16084","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0283"},{"key":"16085","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1587"},{"key":"16086","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01120.x"},{"key":"16087","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840301)53:5<1109::AID-CNCR2820530516>3.0.CO;2-O"},{"key":"16088","doi-asserted-by":"publisher","DOI":"10.5858\/2004-128-863-ACEOFL"},{"key":"16089","unstructured":"\u041c\u0430\u0433\u043e\u043c\u0435\u0434\u043e\u0432\u0430 \u0410.\u0423. \u0414\u0438\u0444\u0444\u0443\u0437\u043d\u0430\u044f \u0412-\u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u0430\u044f \u043b\u0438\u043c\u0444\u043e\u0441\u0430\u0440\u043a\u043e\u043c\u0430 \u043b\u0438\u043c\u0444\u043e\u0438\u0434\u043d\u044b\u0445 \u043e\u0440\u0433\u0430\u043d\u043e\u0432: \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0444\u043e\u0440\u043c\u044b, \u043b\u0435\u0447\u0435\u043d\u0438\u0435: \u0414\u0438\u0441. \u2026 \u0434-\u0440\u0430 \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. \u041c., 2008. \u0421. 183\u20135. [Magomedova AU. Diffuznaya V-krupnokletochnaya limfosarkoma limfoidnykh organov: klinicheskie formy, lechenie. (Diffusive large B-cell lymphosarcoma of lymphoid organs: clinical forms, treatment.) [dissertation] Moscow; 2008. pp. 183\u20135. (In Russ)]"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/450\/416","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/450\/416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T15:32:25Z","timestamp":1764516745000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,1]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2017-10-4-453-463","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2017,10,1]]}}}